701-205-3617EmailRequest Info

CelBank and CelBank Pro

CelBankā„¢ provides storage solutions for stem cells from your skin.

Learn More

Next Healthcare Physicians Nextwork

We invite physicians to join the Next Healthcare, Inc. Network

Learn about the Network

About Next Healthcare

Next Healthcare was founded 2009 with the mission of being the world's leading enabler of personalized regenerative medicine.

Learn More

About Next Healthcare

Next Healthcare Inc. is a biotechnology service that offers Health Conscious consumers the unique opportunity to bank their skin and stem cells for use in future treatment and therapies. We offer processing and long-term secure cryopreservation of your cells. We believe that banking your cells today is a smart step in the direction of planning for a healthy tomorrow.

Technologies that utilize human skin cells and stem cells are rapidly evolving. These approaches may allow individuals to one day treat their diseases or conditions with their own cells.

Current technology now allows us to collect, multiply and store precious stem cells from our bone marrow, blood, adipose tissue, our fat and skin tissue, making it easier than ever to take a pro-active approach to our health through CelBank.

Curt Civin M.D.

Curt Civin M.D. serves as Associate Dean for Research, Director of the Center for Stem Cell Biology & Regenerative Medicine, and Professor of Pediatrics and Physiology of the University of Maryland School of Medicine. Prior to this, he spent a highly successful 30 year tenure at Johns Hopkins Medical School primarily focused on Pediatrics and Oncology as endowed professor and leader. Dr. Civin's pioneering research discoveries include the identification and isolation of CD34+ blood-forming stem-progenitor cells, which dramatically improved stem cell research and led to improved stem cell transplantation for thousands of patients. Dr. Civin's research is focused on the cell and molecular biology of the stem and progenitor cells that form the normal blood and immune systems, and the malignant counterparts of these stem-progenitor cells, the leukemias. Currently, Dr. Civin's lab seeks to understand how the survival, proliferation, and differentiation of normal and malignant stem-progenitor cells are regulated. In basic studies, the Civin lab has comprehensively described which genes, and recently microRNAs, are active and functional in human hematopoietic stem-progenitor cells, using microarrays and amplification strategies. The lab's mission is to translate the resulting understanding and tools to clinical use. Dr. Civin earned a B.A. from Amherst College, and an M.D. cum laude, from Harvard Medical School. He completed Pediatric residency training at Boston Children's Hospital and a fellowship in Pediatric Hematology-Oncology at the National Cancer Institute.

Participation by Dr. Civin as an advisor does not constitute or imply endorsement by the University of Maryland, Baltimore, University System of Maryland or the University of Maryland Medical System.

Terms of ServicePrivacy Policy

Copyright © 2016 Next Heathcare, Inc. - All Rights Reserved

Website Designed and Powered by Delmarva Group